Finance Home - My Yahoo - Yahoo! - Help

Monday, December 21, 2009, 11:52PM ET - U.S. Markets Closed. Dow  0.83% Nasdaq  1.17%

Pulmo BioTech Inc. (PLMO.OB)

At 1:33PM ET: 0.10   0.01 (9.09%)

MORE ON PLMO.OB

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Fri, Dec 11, 2009 • Pulmo BioTech Inc. Announces Status Update Regarding the Regulatory Approval Experiments and Phase I Trials for Its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) Marketwire (Fri, Dec 11) Fri, Dec 4, 2009 • Pulmo BioTech Inc. Announces Further Details of the Background to Its Previously Announced Letter of Intent Regarding the Proposed License of Its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) to the Polish Company, Biotechno Marketwire (Fri, Dec 4) Sat, Nov 21, 2009 • PULMO BIOTECH INC. Financials EDGAR Online Financials (Sat, Nov 21) Tue, Nov 17, 2009 • PULMO BIOTECH INC. Files SEC form 10-Q, Quarterly Report EDGAR Online (Tue, Nov 17) Wed, Nov 11, 2009 • Pulmo BioTech Inc. Announces that Its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) Shows Early Indications of Being Able to Diagnose a Wide Range of Medical Conditions Affecting the Physical and/or Biological Integrity of t PR Newswire (Wed, Nov 11) Fri, Oct 23, 2009 • Pulmo BioTech Inc. Announces Cash Details of its Previously Announced Letter of Intent Intended to Bring its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) to the European Market PR Newswire (Fri, Oct 23) Wed, Oct 21, 2009 • Pulmo BioTech Inc. Announces Further Details of its Previously Announced Letter of Intent Intended to Bring its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) to the European Market PR Newswire (Wed, Oct 21) Tue, Oct 20, 2009 • CEO Interview: Intellect Neurosciences, Inc. - Dr. Daniel G. Chain Wall Street Transcript (Tue, Oct 20) • Pulmo BioTech Inc. Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) PR Newswire (Tue, Oct 20) Wed, Aug 19, 2009 • PULMO BIOTECH INC. Files SEC form 10-Q, Quarterly Report EDGAR Online (Wed, Aug 19) Tue, Jul 14, 2009 • PULMO BIOTECH INC. Files SEC form 10-K, Annual Report EDGAR Online (Tue, Jul 14) Mon, Jun 15, 2009 • PULMO BIOTECH INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online (Mon, Jun 15) Tue, Mar 3, 2009 • PULMO BIOTECH INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online (Tue, Mar 3) • PULMO BIOTECH INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online (Tue, Mar 3) • PULMO BIOTECH INC. Financials EDGAR Online Financials (Tue, Mar 3) Tue, Feb 24, 2009 • PULMO BIOTECH INC. Files SEC form 10-Q, Quarterly Report EDGAR Online (Tue, Feb 24) Older Headlines - Download Recent Headlines View headlines from: Tue, Feb 24, 2009Tue, Feb 17, 2009Tue, Feb 10, 2009Tue, Feb 3, 2009Tue, Jan 27, 2009Tue, Jan 20, 2009Tue, Jan 13, 2009Tue, Jan 6, 2009Tue, Dec 30, 2008Tue, Dec 23, 2008 Add PLMO.OB News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage